Company type | Private |
---|---|
Industry | Neurotechnology |
Founded | June 21, 2016 |
Founder | Elon Musk |
Headquarters | Fremont, California, United States[1] |
Key people | Jared Birchall (CEO)[2] |
Products |
|
Owner | Elon Musk |
Number of employees | c. 300[3] (2022) |
Website | neuralink |
| ||
---|---|---|
Personal
Companies
In popular culture
Second presidency of Trump
Related
|
||
Neuralink Corp.[4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers (Max Hodak, Benjamin Rapoport, Dongjin Seo, Paul Merolla, Philip Sabes, Tim Gardner, Tim Hanson, and Vanessa Tolosa).[4][5][6][7] Neuralink was launched in 2016 and was first publicly reported in March 2017.[8][9][10][11]
In January 2017, Musk approached Pedram Mohseni and Randolph Nudo, who owned the rights to the name “NeuraLink.” These two neuroscientists strived to create an electronic brain chip to treat traumatic brain injury. They made significant progress and completed preliminary testing but could not receive enough funding or support from investors to continue. Musk approached the two and offered tens of thousands of dollars for the company’s name.[12]
The company is based in Fremont, California with plans to build a three-story building with office and manufacturing space near Austin, Texas in Del Valle, located about 10 miles east of Tesla's headquarters and manufacturing plant that opened in 2022.[5]
Since its founding, the company has hired several high-profile neuroscientists from various universities.[13] By July 2019, it had received $158 million in funding (of which $100 million was from Musk) and was employing a staff of 90 employees.[14] At that time, Neuralink announced that it was working on a "sewing machine-like" device capable of implanting very thin (4 to 6 μm in width)[15] threads into the brain, and demonstrated a system that reads information from a lab rat via 1,500 electrodes. They had anticipated starting experiments with humans in 2020,[14] but have since moved that projection to 2023. As of May 2023, they have been approved for human trials in the United States.[6] On January 29, 2024, Musk announced that Neuralink had successfully implanted a Neuralink device in a human and that the patient was recovering.[16]
The company has faced criticism for a large amount of euthanization of primates that underwent medical trials. Veterinary records of the monkeys showed a number of complications with electrodes being surgically implanted.[17]
In September 2024, the company announced that its latest development effort, called Blindsight, will allow those who would otherwise be blind to restore some level of vision, provided the visual cortex is undamaged. The development received "breakthrough" status from the federal government, which will accelerate development.[18]
:10
was invoked but never defined (see the help page).:3
was invoked but never defined (see the help page).The company has hired away several high-profile neuroscientists
:5
was invoked but never defined (see the help page).:4
was invoked but never defined (see the help page).